Because CD4+CD25+ Treg cells are among the most prominent anti-tumor and pro-transplant cells, the regulation of their driving force transcription factor (FoxP3) is a potential site of therapeutic attack [152]. The gene discussed is FOXP3; the disease is neoplasm.